The CDC issued a health advisory on August 11th to notify clinicians about the risk of severe arboviral neuroinvasive disease among patients who are receiving B cell-depleting or B cell-modulating medications, particularly anti-CD20 monoclonal antibodies.
Please see attachment with additional details.
This information has been broadcast to: Health Care Providers; Cardiologists (Monmouth County); Clinics (Monmouth County); Dentists (Monmouth County); Dermatologists (Monmouth County); Family Practice (Monmouth County); General Surgery (Monmouth County); Hematologists/Oncologists (Monmouth County); Infectious Disease (Monmouth County); Internal Medicine (Monmouth County); Neurologists (Monmouth County); Obstetricians/Gynecologists (Monmouth County); Ophthalmologists (Monmouth County); Pediatricians (Monmouth County); Plastic Surgery (Monmouth County); Podiatrists (Monmouth County); Psychiatrists (Monmouth County); Urgent Care (Monmouth County); Health Care Facilities/Other; Behavioral Health Services; Home Care Services; Long Term Care Facilities/Assisted Living; Long Term Care Facilities/Assisted Living (Monmouth County Health Dept.); Hospitals/Acute Care; Hospital CEO; Hospital Emergency Department Director; Hospital Emergency Preparedness Coordinator; Hospital ICU Director; Hospital Infection Control Practitioner; Hospital Medical Director; Hospital Nursing Director; Hospital Quality Liaison; Hospital Safety Officer; Hospital Security Director; Hospitals/Other; Hospitals/Veterans; Labs/Non-Sentinel; Labs/Sentinel; Labs (Monmouth County); Public Health Sector; Always Include (Monmouth County); Local Boards of Health; Local Health Agencies; NJLINCS Community; LINCS Coordinator; LINCS Coordinator Backup; LINCS Epidemiologist; LINCS Health Educator; LINCS Health Officer; LINCS Health Officer Assistant; LINCS Public Health Nurse; LINCS REHS; LINCS Team Member; LOCAL Epidemiologist; LOCAL Health Educators; LOCAL Health Officer; LOCAL Public Health; LOCAL Public Health Nurses; LOCAL REHS; Office of Emergency Management;